When PO** began it's parabolic rise the outstanding shares were 637 million. Now at a share price of around .06, the outstanding shares are about 4 billion. The company diluted the outstanding shares during the price rise. Subsequently, the share price fell.
CGFIA had a similiar price run up over a year ago with a much smaller amount of outstanding shares than it has today at around 10 billion. Like PO**, CGFIA also diluted the shares during a PR campaign. If we were to compare Potage to CGFIA on a price history versus O/S dilution basis, then CGFIA could be valued at near 2 cents.
It would be a far more realistic method of valuation to add up the worth of all assets, reserves and mill earnings potential and factor in the outstanding shares. That is why the patient ones are waiting for assay results and mill progress before making price predictions.
